Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedApr 20, 2026
DataAggregated Company Financials
Companies6
- 7D0.3%
- 3M-2.6%
- 1Y-15.7%
- YTD0.3%
The Pharma is pretty flat in the last 7 days, but Biogened has stood out, gaining 31%. As for the longer term, the industry has declined 16% in the last year. Earnings are forecast to grow by 66% annually.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Apr 2026 | zł1.3b | zł349.3m | -zł146,324,609.00 | 12.1x | -9x | 3.8x |
| Thu, 19 Mar 2026 | zł1.3b | zł349.3m | -zł146,324,610.00 | 9.5x | -9.1x | 3.8x |
| Sat, 14 Feb 2026 | zł1.5b | zł350.2m | -zł145,356,482.00 | 9x | -10.3x | 4.3x |
| Mon, 12 Jan 2026 | zł1.4b | zł350.2m | -zł145,356,482.00 | 9.2x | -9.4x | 3.9x |
| Wed, 10 Dec 2025 | zł1.3b | zł347.8m | -zł145,259,568.00 | 9x | -9.2x | 3.9x |
| Fri, 07 Nov 2025 | zł1.4b | zł327.3m | -zł92,057,875.00 | 8.9x | -15x | 4.2x |
| Sun, 05 Oct 2025 | zł1.5b | zł327.7m | -zł93,055,146.00 | 10.1x | -15.9x | 4.5x |
| Tue, 02 Sep 2025 | zł1.5b | zł333.9m | -zł72,252,084.00 | 10.4x | -20.4x | 4.4x |
| Thu, 31 Jul 2025 | zł1.5b | zł333.7m | -zł73,417,994.00 | 13.1x | -21x | 4.6x |
| Sat, 28 Jun 2025 | zł1.4b | zł333.7m | -zł73,417,994.00 | 13.7x | -19.2x | 4.2x |
| Mon, 26 May 2025 | zł1.5b | zł332.3m | -zł73,463,661.00 | 15.7x | -20.5x | 4.5x |
| Wed, 23 Apr 2025 | zł1.6b | zł324.0m | -zł12,792,856.00 | 44x | -127.9x | 5x |
| Fri, 21 Mar 2025 | zł1.7b | zł322.6m | -zł12,258,563.00 | 46.1x | -136.7x | 5.2x |
| Sun, 16 Feb 2025 | zł1.6b | zł318.5m | -zł9,304,995.00 | 41.8x | -167.1x | 4.9x |
| Tue, 14 Jan 2025 | zł1.6b | zł318.9m | -zł9,295,998.00 | 43.2x | -175.6x | 5.1x |
| Thu, 12 Dec 2024 | zł1.6b | zł360.7m | -zł14,404,163.00 | 40.7x | -110.2x | 4.4x |
| Sat, 09 Nov 2024 | zł1.7b | zł314.5m | -zł72,767,518.00 | 11.9x | -23.9x | 5.5x |
| Mon, 07 Oct 2024 | zł1.8b | zł314.9m | -zł72,051,939.00 | 10.5x | -24.7x | 5.6x |
| Wed, 04 Sep 2024 | zł2.0b | zł317.3m | -zł60,178,104.00 | 11.6x | -32.5x | 6.2x |
| Fri, 02 Aug 2024 | zł1.7b | zł310.8m | -zł61,217,640.00 | 11.2x | -27.7x | 5.4x |
| Sun, 30 Jun 2024 | zł1.1b | zł310.8m | -zł61,217,640.00 | 13.1x | -18.4x | 3.6x |
| Tue, 28 May 2024 | zł1.1b | zł312.1m | -zł61,350,052.00 | 10x | -18.5x | 3.6x |
| Thu, 25 Apr 2024 | zł1.1b | zł311.5m | -zł40,173,065.00 | 15.1x | -27.7x | 3.6x |
| Sat, 23 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 18x | -29.2x | 3.8x |
| Mon, 19 Feb 2024 | zł1.2b | zł311.5m | -zł40,062,919.00 | 16.1x | -30x | 3.9x |
| Wed, 17 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 12.8x | -29x | 3.7x |
| Fri, 15 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.2x | -30.9x | 4x |
| Sun, 12 Nov 2023 | zł1.1b | zł302.0m | -zł44,782,495.00 | 11.9x | -24.9x | 3.7x |
| Tue, 10 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.6x | -26.2x | 3.7x |
| Thu, 07 Sep 2023 | zł1.2b | zł287.0m | -zł53,857,118.00 | 10.7x | -22.4x | 4.2x |
| Sat, 05 Aug 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.6x | -21.9x | 4.2x |
| Mon, 03 Jul 2023 | zł1.1b | zł278.4m | -zł53,806,540.00 | 36.8x | -21.3x | 4.1x |
| Wed, 31 May 2023 | zł1.1b | zł282.1m | -zł51,108,194.00 | 35.3x | -22.5x | 4.1x |
| Fri, 28 Apr 2023 | zł1.1b | zł272.8m | -zł43,525,989.00 | 8.9x | -25.8x | 4.1x |
Price to Earnings Ratio
-25.8x
Current Industry PE
- Investors are pessimistic on the Polish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.4x is higher than the industry's current PS ratio of 3.8x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 8.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 2.13% | |
| Healthcare | 3.87% | |
| Pharma | 0.31% | |
| Pharma | 0.31% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BGD Biogened | zł19.80 | 13.8% +zł5.9m | -26.1% | PE10.5x | |
| MOC Molecure | zł5.25 | 2.7% +zł2.9m | -34.7% | PS18.5x |